Ligand Pharmaceuticals Inc

Insider Reports History

Location
3911 Sorrento Valley Blvd, Suite 110, San Diego, CA
Signature
/s/ Octavio Espinoza, Chief Financial Officer of Ligand Pharmaceuticals Incorporated
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ligand Pharmaceuticals Inc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pelthos Therapeutics Inc. 10%+ Owner Common Stock 1.5M $15M $10.00 Jul 1, 2025 Direct
Pelthos Therapeutics Inc. 10%+ Owner Series A Convertible Preferred Stock 34.3K Jul 1, 2025 Direct
OmniAb Operations, Inc. 10%+ Owner Common Stock 0 Nov 1, 2022 Direct

Insider Reports Filed by Ligand Pharmaceuticals Inc

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PTHS Pelthos Therapeutics Inc. Jul 1, 2025 3 $15M 4 Jul 3, 2025 10%+ Owner
PTHS Pelthos Therapeutics Inc. Jul 1, 2025 0 $0 3 Jul 3, 2025 10%+ Owner
NONE OmniAb Operations, Inc. Nov 1, 2022 1 $0 4 Nov 3, 2022 10%+ Owner
NONE OmniAb, Inc. Sep 30, 2022 0 $0 3 Sep 30, 2022 10%+ Owner